Endocrine Abstracts

Introduction: Endocrine disrupting chemicals (EDC) are exogenous substances altering function(s) of the endocrine system. EDCs have been implicated in the decline in male reproductive health. We aimed to systematically review the pathophysiological effects of EDCs on male reproductive health.Methods: Searches of EMBASE, MEDLINE and PubMed were conducted using the following terms: ‘endocrine disrupt*’ OR ‘endocrine disruptors’ OR &#145...

Background: Testosterone replacement therapy (TRT) is widely used for the treatment of symptomatic hypogonadism in men. However, data on prescription behaviours of TRT are limited. The objective of this study was to investigate clinical characteristics associated with the likelihood of being prescribed TRT by general practitioners (GPs) in North West London (NWL).Methods: We carried out a retrospective cohort study using Discover database of GP-registere...

Introduction: Over half of postmenopausal women suffer symptoms which can sometimes be non-responsive to hormone replacement therapy (HRT). Testosterone is implicated in regulating urogenital and sexual function in women. However, using testosterone therapy in postmenopausal women remains highly controversial, principally due to the lack of syndromic relationship between serum testosterone levels and onset of sexual dysfunction during menopause. Clinical practice is therefore ...

Background: Recurrent pregnancy loss (RPL) affects 1–2% couples, and is defined as ≧3 consecutive pregnancy losses before 20-weeks’ gestation. RPL is caused by foetal chromosomal abnormalities, or maternal factors such as thrombophilia. It was recently reported that men with RPL have high levels of sperm DNA fragmentation (a marker of infertility); however, the cause of this damage is currently not known. Seminal plasma has high levels of granulocyte-derived o...

Background: Recurrent pregnancy loss (RPL) affects 1–2% couples, and is defined as ≧3 consecutive pregnancy losses before 20-weeks’ gestation. RPL is caused by foetal chromosomal abnormalities, or maternal factors such as thrombophilia. It was recently reported that men with RPL have high levels of sperm DNA fragmentation (a marker of infertility); however, the cause of this damage is currently not known. Seminal plasma has high levels of granulocyte-derived o...

Case: A 19-year-old British-Asian man presented with a two-year history of gynaecomastia. He had no other symptoms of hypogonadism. On examination, BMI was 28 kg/m2 and he had post-pubertal-sized testes (20 ml) with normal secondary sexual characteristics. Hypogonadism was confirmed by two morning fasting total testosterone levels of 4.7 and 5.2 (RR 9.2–31.6 nmol/l). Haemoglobin was normal (152 g/l) and serum oestradiol was <100 pmol/l. He had inappropriate...

Background: Kisspeptin is a novel hypothalamic hormone with powerful stimulatory effects on the hypothalamo-pituitary–gonadal (HPG) axis. Inactivating mutations in the kisspeptin receptor lead to pubertal failure. We have previously demonstrated that injection of kisspeptin-54 stimulates LH release in healthy men and women. Recent studies in animals suggest that endogenous kisspeptin may be involved in stimulating the GnRH pulse generator. Determining whether exogenous ad...

Background: Millions of men worldwide take anabolic-androgenic steroids (AAS) to boost muscle growth, but risk psychosis, cardiomyopathy, stroke and death. Users avoid stopping AAS because they are fearful of low testosterone symptoms including sexual dysfunction, depression and suicidality. To avoid these symptoms, men often illicitly self-medicate a 2–12-week course of drugs including selective oestrogen receptor modulators to boost testicular function ...

Clinical Endocrinology 2016 84 939–945. DOI: 10.1111/cen.12603...

Clinical Endocrinology 2016 84 939–945. DOI: 10.1111/cen.12603...